Susunod

Auto-play

Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL

0 Mga view • 07/14/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

In this episode, Mark Geyer and colleagues demonstrate that second-generation CD19-targeted CAR T cell therapy following conditioning chemotherapy is tolerated in patients with relapsed/refractory CLL and can result in complete remission in a subset of patients…

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play